Adaptive Biotechnologies (NASDAQ:ADPT) stock rises as Goldman Sachs upgrades to 'Buy,' citing an attractive end market. Read more here.

Europe's battery tech sector faces a new choice: collaborate with China's industry giants or focus on the next frontier.

In recent years, hair transplantation has evolved from a niche procedure to a mainstream solution for hair loss concerns. London, ...

Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...

Scientists are developing bacteria-based cancer therapies to target and destroy cancer cells, offering hope for more effective treatments.